Editors' Note: This article covers a stock trading at less than $1 per share and/or with less than a $100 million market cap. Please be aware of the risks associated with these stocks.
Cel-Sci (NYSEMKT:CVM) is a lead investigational immunotherapy company which is developing a groundbreaking technology to treat head and neck cancer, as well as ways to enhance the body's immune system capability to fight bacterial, viral, and parasitic infections. It's a $65 million sized micro-cap listed on the AMEX. Just 2 weeks ago, a remarkable insider transaction took place:
(click to enlarge)
The CEO doubled his position by buying 300000 shares (!) directly in the open market - not an option transaction - at a price...
|FREE||SA PRO MEMBERS|
|IDEA GENERATOR||X||Exclusive access to 10 PRO ideas every day|
|INVESTING IDEAS LIBRARY||X||Exclusive access to PRO library of more than 15,000 ideas|
|SECTOR EXPERT NETWORK||X||Exclusive access to all sector experts for direct consultation|
|PERFORMANCE TRACKING||X||Track performance of all PRO stock ideas|
|PROFESSIONAL TOOLS||X||Professional Idea Filters to zero-in based on industry, market cap and more|